Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Evaluation of the interaction between tumor growth factor-β and interferon type I pathways in patients with COVID-19: focusing on ages 1 to 90 years

Fig. 3

Illustrates serum levels of TGF-β (A), IFN-α (B), and SERPINE1 (C) in all enrolled patients compared with all healthy subjects in the control group. In addition, serum levels of TGF-β (D), IFN-α (E), and SERPINE1 (F) are shown based on disease severity (moderate/severe). The data are presented as mean ± SD. A P value less than 0.05 is considered statistically significant

Back to article page